Ferreri, Andrés J. M.
Calimeri, Teresa
Cwynarski, Kate
Dietrich, Jorg http://orcid.org/0000-0001-8291-0136
Grommes, Christian
Hoang-Xuan, Khê
Hu, Leland S.
Illerhaus, Gerald http://orcid.org/0000-0002-0009-8138
Nayak, Lakshmi
Ponzoni, Maurilio
Batchelor, Tracy T.
Article History
Accepted: 8 May 2023
First Online: 15 June 2023
Competing interests
: A.J.M.F. has received speaker fees from Adienne, AstraZeneca, Bristol Myers Squibb, Gilead, Novartis and Roche; was a member of advisory boards of Abbvie, AstraZeneca, Bristol Myers Squibb, Genmab, Gilead, Incyte, Juno, Novartis, PletixaPharm and Roche; currently receives research grants from Abbvie, Amgen, ADC Therapeutics, Bayer HealthCare Pharmaceuticals, Beigene, Bristol Myers Squibb, Genmab, Gilead, Hutchison Medipharma, Incyte, Janssen Research & Development, MEI Pharma, Novartis, Pfizer, Pharmacyclics, PletixaPharm, Protherics, Roche and Takeda; and holds patents on NGR-hTNF-α in brain tumours and NGR-hTNF/R-CHOP in relapsed or refractory PCNSL and SNGR-hTNF in brain tumours. K.C. has received speaker fees from Roche, Takeda, Kite, Gilead, Incyte and Celgene/BMS as well as consulting fees from Roche, Takeda, Celgene, Atara, Gilead, KITE, Janssen and Incyte. J.D. has been a consultant for Blue Earth Diagnostics, Magnolia and Unum Therapeutics; has received research support from Beacon Biosignals, Boehringer Ingelheim, Bristol Myers Squibb, Medimmune, Acerta Pharma and Orbus Therapeutics; and has received royalties from Wolters Kluwer for serving as an author for UpToDate. C.G. has received research support from Pharmacyclics, Bayer, and Bristol Myers Squibb and has acted as a consultant for Kite, BTG and ONO. K.H.-X. has received consulting fees from BTG. L.S.H. is co-founder of Precision Oncology Insights. G.I. has received speaker fees from Roche and Gilead; was a member of advisory boards of Gilead, Incyte, and Roche and received research fundings from the German Ministry of Science. L.N. has consulted for Ono Pharmaceutical, Genmab and BraveBio, has received clinical trial research support from Merck, Kazia and AstraZeneca, and delivered Continuing Medical Education lectures for Oakstone Medical Publishing and Neurology Audio Digest. T.C. has received consulting fees from Janssen-Cilag. M.P. and T.T.B. declare no competing interests.